Candido
Díaz Rodríguez
University College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de University College London (1)
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184